Meta-analysis: Therapeutic effect of transcatheter arterial chemoembolization combined with Compound Kushen Injection in hepatocellular carcinoma

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 9, Issue 2, 2012, Pages

  Sun, Qizhe ^a   Ma, Wenli ^a   Gao, Yuan ^a   Zheng, Wenling ^a   Zhang, Bao ^a   Peng, Yifei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Compound Kushen Injection; Hepatocellular carcinoma; TACE; Transcatheter arterial chemoembolization

Indexed keywords

ANTINEOPLASTIC AGENT; COMPOUND KUSHEN INJECTION; UNCLASSIFIED DRUG; HERBACEOUS AGENT; KUSHEN;

ABDOMINAL DISEASE; ABDOMINAL DISTENTION; ABDOMINAL PAIN; ANTIANGIOGENIC ACTIVITY; ARTICLE; BONE MARROW DEPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPARATIVE EFFECTIVENESS; DIARRHEA; DRUG RESPONSE; HETEROSMILACIS JAPONICAE; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER FAILURE; MEDICINAL PLANT; META ANALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOPHORA FLAVESCENS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR REGRESSION; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; PHYTOTHERAPY; SOPHORA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DRUGS, CHINESE HERBAL; HUMANS; LIVER NEOPLASMS; PHYTOTHERAPY; SOPHORA; TREATMENT OUTCOME;

EID: 84885471396     PISSN: None     EISSN: 01896016     Source Type: Journal    
DOI: 10.4314/ajtcam.v9i2.1     Document Type: Article

References (28)

1. Bruix, J. and J. M. Llovet (2002). Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology.35(3): 519-524.
2. Cao, J., Wang, Z. L., Fang, J., Liu, H. Q., He, Y. (2009). Clinical Study of Compound Kushen Injection Combined with TACE for Treatment of Advanced Liver Cancer. Shandong Medicine. 49(4): 74-76.
3. Chen, G. H., Li, S.R., Yang, L., (2007). Therapeutic effects of complex kushen injection combined with double interventional therapy on treating primary hepatocarcinoma. Chin J Int egr T rad West Med Dig. 15(4): 239-241.
4. Chen, Y. H. (2009). Efficacy of transcatheter arterial chemoembolization combined with complex prescription kushen injection in the treatment of primary advanced liver cancer. China Modern Medicine. 16(17): 5-6.
5. Chen, Y. L., Jia, Y. J., Zhang, Y., (2006). Clincial effect Observation of Complex Sophorae Injection Combining with Chemotherapy on Treating Liver Cancer. Journal of Tianjin University of Traditional Chinese Medicine. 25(3): 166-167.
6. Chung, J. W., Park, J. H., Han, J. K., Choi, B. I., Han, M. C., Lee, H. S., Kim, C. Y. (1996). Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology. 198(1): 33-40.
7. Deng, L., Li, Z. W., Wu, H. T., Lu, Q. H., Chen, L. Z., Wu, J. Y., Wu, X. Y., Chen, Q. Q., (2009). Therapeutic Effect of Continuous Infusion of Compound Kushen Injection Combined with Hepatic Arterial Chemoembolization for Advanced Liver Cancer: An Observation of 20 Cases. Journal of New Chinese Medicine. 41(4): 28-29.
8. Ferlay, J., Shin, H.R., Bray, F., (2008) GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase [DB/OL]. http://globocan.iarc.fr.
9. Guan, C. N., Cai, L.Z., Yue, L. Q., Zhang, Y., (2006). Clinicel study on treatment of advanced primary liver cancer by Yanshu injection combining with chemotherapy. China Journal of Chinese Materia Medica. 31(6): 510-512.
10. Higgins, JPT, Green, S.,(editors) (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from http://www.cochrane-handbook.org.
11. Huang, R. W., Chen, S. X., Huang, X. P., (2006). Clinical Observation On Advanced Primary Hepatic Carcinoma Treated by Yanshu Injection Combined with Transcatheter Arterial Chemoembolization. Hebei Medicine. 12(5): 443-445.
12. Li, M., Qian, X.P., Liu, B. R., (2007). Experimental Study of Composite Radix Sophora Flavescentis Injection with Thermotherapy Inhibiting Angiogenesis. Journal of Clinical Medicine in Practice. 11(3): 57-61.
13. Li, R., Du, J.P., Hou, Y. S., Chen, Z. T., (2006). Experimental study of Yanshu injection acted on SGC-7901, HepG2 and BEL-7402 tumor cell. Cancer Research and Clinic. 18(1): 8-10.
14. Lin, L., Zhou, D. H., Chen, Y., Liu, Q. H., Chen, X. X., (2009). Experimental Study of Anti - tumor Effect of Compound Radix Sophorae Flavescentis Injection on Lung Cancer Cells and Hepatic Carcinoma Cells. Traditional Chinese Drug Research & Clinical Pharmacology. 20(1): 21-23.
15. Miller, A. B., Hoogstraten, B., Staquet, M., Winkler, A., (1981). Reporting results of cancer treatment. Cancer. 47(1): 207-214.
16. Roche, A., Girish, B. V., de Baere, T., Baudin, E., Boige, V., Elias, D., Lasser, P., Schlumberger, M., Ducreux, M., (2003). Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol. 13(1): 136-140.
17. Stuart, K., (2003). Chemoembolization in the management of liver tumors. Oncologist. 8(5): 425-437.
18. Therasse, P., (2002). Evaluation of response: new and standard criteria. Ann Oncol. 13 Suppl 4: 127-129.
19. Tong, H. Z., (2010). The observation of the clinical effects of transcatheter arterial chemoembolization and complex prescrption kuseng injection on the advanced period of liver cancer. Jiangxi Medical Journal. 45(7): 637-639.
20. Venook, A. P., Stagg, R. J., Lewis, B. J., Chase, J. L., Ring, E. J., Maroney, T. P., Hohn, D. C., (1990). Chemoembolization for hepatocellular carcinoma. J Clin Oncol. 8(6): 1108-1114.
21. Wang, H. M., Cheng, X. M. (2009). Composite Kushen injection combined with hepatic artery embolism on unresectable primary liver cancer. Modern Journal of Integrated Traditional Chinese and Western Medicine. 18(12): 1334-1335.
22. Xu, P., Wang, W.D., Lu, J., Fan, C., (2010). Efficacy of Compound Kushen Injection in the Prevention and Treatment of the Adverse Reactions Following Transcatheter Hepatic Arterial Chemoembolization in Patient with Liver Cancer. Evaluation and analysis of drug-use in hospitals of China. 10(5): 457-458.
23. Yang, S. M., (2006). Yan Shu Injecdtion Combined with Chemotherapy on Treating advanced primary liver cancer. Medicine Industry Information. 3(17): 209-210.
24. Yates, J. W., Chalmer, B., McKegney, F. P., (1980). Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 45(8): 2220-2224.
25. Yu, M. L., Kang, X.H., (2009). Clinical Study of Compound Kushen Injection Combined with Hepatic Arterial Chemoembolization for Primary Liver Cancer. Guide of China Medicine. 8(7): 123-125.
26. Zhang, A. M., Wang, W. M., Wu, J. J., (2006). Effect of Yanshu on Primary Hepatic Carcinoma Treated with Interventional Therapy. Evaluation and analysis of drug-use in hospitals of China. 6(6): 374-375.
27. Zhu, X. F., Li, G. A., (2006). Study of Yanshu injection combined with chemoembolization on middle and advanced stage liver cancer. Modern Journal of Integrated Traditional Chinese and Western Medicine. 15(4): 431-432.
28. Zhu, Y. Z., Kong, X.B., Yan, L., (2011). Effect of compound radix sophorae flavescentis injection on Hedgehog signaling pathway activation in rat hepatocarcinoma models. Journal of Clinical Rehabilitative Tissue Engineering Research. 15(2): 257-260.